Publication:
How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria

dc.contributor.authorArjen M. Dondorpen_US
dc.contributor.authorFrank M. Smithuisen_US
dc.contributor.authorCharley Woodrowen_US
dc.contributor.authorLorenz von Seidleinen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherMyanmar Oxford Clinical Research Uniten_US
dc.date.accessioned2018-12-21T07:59:13Z
dc.date.accessioned2019-03-14T08:03:52Z
dc.date.available2018-12-21T07:59:13Z
dc.date.available2019-03-14T08:03:52Z
dc.date.issued2017-05-01en_US
dc.description.abstract© 2017 The Author(s) In the Greater Mekong subregion (GMS), artemisinin resistance is increasingly compounded by partner drug resistance, causing high failure rates of artemisinin combination therapies in some areas. For its containment, an accelerated elimination strategy will be needed. This includes high-quality implementation of conventional malaria control measures: early case management with quality artemisinin combination therapies (avoiding artesunate monotherapies) and single gametocytocidal low dose of primaquine, vector control and surveillance. Village health workers (VHWs) play a key role in the provision of community-based services which have to reach even the most remote populations. Additional, more aggressive, approaches will be important to accelerate malaria elimination, which could include mass drug administrations, potentially in combination with ivermectin and vaccination, mass screening and treatment with novel diagnostics, reactive case detection, and other measures.en_US
dc.identifier.citationTrends in Parasitology. Vol.33, No.5 (2017), 353-363en_US
dc.identifier.doi10.1016/j.pt.2017.01.004en_US
dc.identifier.issn14715007en_US
dc.identifier.issn14714922en_US
dc.identifier.other2-s2.0-85011628834en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/42833
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011628834&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleHow to Contain Artemisinin- and Multidrug-Resistant Falciparum Malariaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85011628834&origin=inwarden_US

Files

Collections